Skip to Main Content

Author Details

Raluca Ionescu-Ittu
Analysis Group Inc.
2007
72
28
PMIDPaper TitleJournal TitlePublished Year
36872338Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.Osteoporos Int2023
37715853Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+â¿¿Metastatic Breast Cancer.Oncol Ther2023
37659039Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens.Drugs Real World Outcomes2023
34874547Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease in the U.S. Real-World Settings.Rheumatol Ther2022
35352855Health-care resource use and costs associated with diabetic and idiopathic gastroparesis: A claims analysis of the first 3 years following the diagnosis of gastroparesis.Neurogastroenterol Motil2022
34282527Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors.Adv Ther2021
33602461Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.J Am Coll Cardiol2021
33906368Real-world genetic testing patterns in metastatic castration-resistant prostate cancer.Future Oncol2021
33560066The Economic Burden of Tenosynovial Giant Cell Tumors Among Employed Workforce in the United States.J Occup Environ Med2021
33609268Disease Management and Outcomes in Patients Hospitalized for Acute Heart Failure in Japan.Cardiol Ther2021
34521444Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.Pediatr Rheumatol Online J2021
34219723Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.J Alzheimers Dis2021
34373223Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study.Clin Genitourin Cancer2021
32929647The Economic Value of Improved Productivity from Treatment of Chronic Hepatitis C Virus Infection: A Retrospective Analysis of Earnings, Work Loss, and Health Insurance Data.Adv Ther2020
32800512In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States.JACC Heart Fail2020
30317881Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study.Future Oncol2019
31871622Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review.Melanoma Manag2019
31819914Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex.Epilepsia Open2019
30247203Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive.Melanoma Res2019
31207185Secular trends in pregnancy rates, delivery outcomes, and related health care utilization among women with congenital heart disease.Congenit Heart Dis2019
31452397Second-line rituximab-bendamustine versus rituximab-gemcitabine-oxaliplatin in diffuse large B-cell lymphoma in the real world.J Comp Eff Res2019
30929841Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration.Eur Urol Oncol2019
29025274Overall survival in patients with glioblastoma before and after bevacizumab approval.Curr Med Res Opin2018
30216199Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma.Melanoma Res2018
30157797Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication.BMC Infect Dis2018
30009647Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenibâ¿¿+â¿¿trametinib versus nivolumab or pembrolizumab monotherapy.Curr Med Res Opin2018
30439947Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimus.PLoS One2018
29656745Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy.Lung Cancer2018
29333579Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center.Int Urol Nephrol2018
28522158Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.Clin Lung Cancer2017
27047721Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice.Springerplus2016
26538581Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures in Patients With Congenital Heart Disease: 15-Year Data From a Population-Based Longitudinal Cohort.Circulation2016
27702435Prevalence of Cancer in Adults With Congenital Heart Disease Compared With the General Population.Am J Cardiol2016
26890629Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.Liver Transpl2016
27107569Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer.Breast Cancer Res Treat2016
24934436Clinicians' perspectives on patient satisfaction in adult congenital heart disease clinics--a dimension of health care quality whose time has come.Congenit Heart Dis2015
25791800Psoriasis and risk of diabetes-associated microvascular and macrovascular complications.J Am Acad Dermatol2015
25475685A difference-in-differences approach to estimate the effect of income-supplementation on food insecurity.Prev Med2015
24485223Long-term cost-effectiveness of transcatheter versus surgical closure of secundum atrial septal defect in adults.Int J Cardiol2014
27202155Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting.Value Health2014
25439437Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study.Lung Cancer2014
25025755Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.Curr Med Res Opin2014
24944314Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.Circulation2014
24959693Distribution and drivers of costs in type 2 diabetes mellitus treated with oral hypoglycemic agents: a retrospective claims data analysis.J Med Econ2014
24589851Specialized adult congenital heart disease care: the impact of policy on mortality.Circulation2014
23517347Comparing nilotinib with dasatinib as second-line therapies in patients with chronic myelogenous leukemia resistant or intolerant to imatinib -- a retrospective chart review analysis.Curr Med Res Opin2013
24060942Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors.Circulation2013
24236513Complex questions command complex analyses: comparative effectiveness of drug treatment strategies in atrial fibrillation.J Comp Eff Res2013
23602461Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults.JACC Cardiovasc Interv2013
23644083Sex differences in hospital mortality in adults with congenital heart disease: the impact of reproductive health.J Am Coll Cardiol2013
  • 1 - 50 of 72

Recommended Authors

Suveen Angraal
Cardiovascular medicine clinical fellow at the Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Ruijun Chen
USA Tempus Labs Inc.
Career Start Year 2012
Number of shared co-authors 0
Azza Shoaibi
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 0
Orestis A Panagiotou
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 0
Rohan Khera
Yale School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Michael O Harhay
University of Pennsylvania, Perelman School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Benjamin P Geisler
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 0
Nicholas Mitsakakis
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Nilay D Shah
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 0
Soko Setoguchi
Rutgers University Institute for Health, the State University of New Jersey
Career Start Year 2001
Number of shared co-authors 0
Lesley H Curtis
Duke Clinical Research Institute
Career Start Year 1999
Number of shared co-authors 0
Jill M Killian
Department of Quantitative Health Sciences Mayo Clinic Rochester MN USA.
Career Start Year 1999
Number of shared co-authors 0
Chi-Hong Tseng
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
Manisha Desai
Stanford University
Career Start Year 1997
Number of shared co-authors 0
Yong-Fang Kuo
University of Texas Medical Branch at Galveston
Career Start Year 1997
Number of shared co-authors 0
Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 1
George Tomlinson
University Health Network
Career Start Year 1994
Number of shared co-authors 0
Andrew J Epstein
University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Derek B Boothroyd
Stanford University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Todd A MacKenzie
Geisel School of Medicine at Dartmouth
Career Start Year 1992
Number of shared co-authors 0
Harlan M Krumholz
Yale School of Medicine
Career Start Year 1988
Number of shared co-authors 2
Til St??rmer
University of North Carolina at Chapel Hill
Career Start Year 1988
Number of shared co-authors 0
Mark G Weiner
Weill Cornell Medical College
Career Start Year 1987
Number of shared co-authors 1
Therese A Stukel
and Institute of Health Policy, University of Toronto
Career Start Year 1986
Number of shared co-authors 0
Muhammad Mamdani
Institute of Health Policy, University of Toronto
Career Start Year 1984
Number of shared co-authors 0
Endel J Orav
Brigham and Women's Hospital
Career Start Year 1982
Number of shared co-authors 3
Elizabeth A Chrischilles
University of Iowa, School of Public Health
Career Start Year 1982
Number of shared co-authors 0
Stephan D Fihn
University of Washington
Career Start Year 1980
Number of shared co-authors 0

Collaborators

Ariane Marelli
Jewish General Hospital, McGill University
Co-authored papers 22
Brian Barnett
Co-authored papers 3
Michelle Gurvitz
Boston Children's Hospital
Co-authored papers 3
Paul Khairy
Montreal Heart Institute, Universite de Montreal
Co-authored papers 2
Gary Michael Felker
Duke University School of Medicine
Co-authored papers 2
Christo I Tchervenkov
The Montreal Children's Hospital of the McGill University Health Centre
Co-authored papers 2
Caroline Robert
Co-authored papers 1
Ronen Rozenblum
Brigham and Women's Hospital
Co-authored papers 1
Susanna Y Huh
Ironwood Pharmaceuticals
Co-authored papers 1
Michael J Landzberg
Harvard Medical School
Co-authored papers 1
Carlo Torti
&quotMagna Graecia&quot University
Co-authored papers 1
Pablo Cervantes
McGill University Health Centre.
Co-authored papers 1
Kathy J Jenkins
Boston Children's Hospital
Co-authored papers 1
David W Bates
Brigham and Women's Hospital Division of General Internal Medicine
Co-authored papers 1
Diederick E Grobbee
Co-authored papers 1
Mark S Sulkowski
Johns Hopkins University School of Medicine
Co-authored papers 1
Aihua Liu
Douglas Research Centre
Co-authored papers 1
Amy Verstappen
University of Maryland School of Medicine in Baltimore
Co-authored papers 1
Ann Gianola
Co-authored papers 1
Release 1.2